Gisèle Bonne Selected Research

Lamins

1/2023	Caenorhabditis elegans models for striated muscle disorders caused by missense variants of human LMNA.
1/2021	Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.
1/2021	The non-muscle ADF/cofilin-1 controls sarcomeric actin filament integrity and force production in striated muscle laminopathies.
12/2020	Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth.
10/2020	Protein Kinase C Alpha Cellular Distribution, Activity, and Proximity with Lamin A/C in Striated Muscle Laminopathies.
7/2020	Activation of sarcolipin expression and altered calcium cycling in LMNA cardiomyopathy.
1/2020	Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells.
12/2019	Microtubule cytoskeleton regulates Connexin 43 localization and cardiac conduction in cardiomyopathy caused by mutation in A-type lamins gene.
9/2019	Effect of genetic background on the cardiac phenotype in a mouse model of Emery-Dreifuss muscular dystrophy.
10/2018	N-acetyl cysteine alleviates oxidative stress and protects mice from dilated cardiomyopathy caused by mutations in nuclear A-type lamins gene.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gisèle Bonne Research Topics

Disease

24	Laminopathies 01/2023 - 01/2005
17	Cardiomyopathies (Cardiomyopathy) 01/2021 - 06/2002
15	Muscular Dystrophies (Muscular Dystrophy) 12/2020 - 06/2002
15	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2019 - 01/2005
13	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2020 - 12/2002
10	Muscular Diseases (Myopathy) 04/2019 - 06/2007
7	Heart Failure 07/2020 - 04/2003
6	Autosomal Emery-Dreifuss Muscular Dystrophy 01/2021 - 01/2005
5	Fibrosis (Cirrhosis) 01/2016 - 01/2005
4	Left Ventricular Dysfunction 01/2016 - 04/2003
4	Sudden Death 09/2012 - 01/2005
3	Inborn Genetic Diseases (Disease, Hereditary) 12/2019 - 01/2013
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2019 - 08/2017
3	Heart Diseases (Heart Disease) 01/2018 - 05/2007
3	Disease Progression 01/2018 - 01/2012
3	Premature Aging 08/2015 - 11/2011
3	Lipodystrophy 05/2014 - 06/2002
2	Rare Diseases (Rare Disease) 01/2021 - 12/2020
2	Hypertrophy 12/2020 - 07/2012
2	Muscle Weakness 04/2019 - 09/2015
2	Cardiac Arrhythmias (Arrythmia) 01/2018 - 09/2012
2	Progeria (Hutchinson Gilford Syndrome) 08/2015 - 05/2014
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2014 - 11/2014
2	X-Linked Emery-Dreifuss Muscular Dystrophy 05/2014 - 06/2007
2	type 1B Limb-girdle muscular dystrophy 03/2012 - 12/2003
2	Familial Partial Lipodystrophy (Dunnigan Syndrome) 06/2007 - 08/2002
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 01/2021
1	Rupture 01/2020
1	Bites and Stings (Sting) 10/2019
1	Infections 10/2019
1	Channelopathies 03/2019
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 03/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Ventricular Tachycardia 01/2019
1	Lmna-Related Congenital Muscular Dystrophy 03/2018
1	Congenital myasthenic syndrome with episodic apnea 01/2016
1	Cognitive Dysfunction 01/2016
1	Contracture 12/2015
1	Epilepsy (Aura) 09/2015
1	Limb-girdle muscular dystrophy type 2H 07/2015

Drug/Important Bio-Agent (IBA)

33	Lamin Type A (Lamin A)IBA 10/2020 - 06/2002
23	LaminsIBA 01/2023 - 08/2002
16	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2002
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018 - 01/2009
4	Mitogen-Activated Protein KinasesIBA 01/2011 - 08/2007
3	Intermediate Filament ProteinsIBA 01/2021 - 01/2009
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2011
3	Protein Isoforms (Isoforms)IBA 08/2015 - 07/2010
2	EnzymesIBA 01/2021 - 03/2019
2	CalciumIBA 07/2020 - 04/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2019 - 10/2006
2	emerinIBA 01/2019 - 11/2016
2	ConnectinIBA 12/2018 - 12/2015
2	HeterochromatinIBA 01/2016 - 01/2005
2	CollagenIBA 09/2015 - 09/2011
2	DystrophinIBA 11/2014 - 11/2014
2	Peptides (Polypeptides)IBA 08/2013 - 07/2012
2	MicroRNAs (MicroRNA)IBA 01/2013 - 11/2011
2	JNK Mitogen-Activated Protein KinasesIBA 01/2011 - 07/2010
1	Antiviral Agents (Antivirals)IBA 04/2021
1	VaccinesIBA 04/2021
1	Serine (L-Serine)FDA Link 01/2021
1	Histone DemethylasesIBA 01/2021
1	Cofilin 1IBA 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	Protein Kinase C-alphaIBA 10/2020
1	sarcolipinIBA 07/2020
1	Connexin 43 (Connexin43)IBA 12/2019
1	TubulinIBA 12/2019
1	VitaminsIBA 03/2019
1	NucleosidesIBA 11/2018
1	NAD (NADH)IBA 11/2018
1	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2018
1	pyridineIBA 11/2018
1	nicotinamide-beta-ribosideIBA 11/2018
1	Cysteine (L-Cysteine)FDA Link 10/2018
1	Messenger RNA (mRNA)IBA 03/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	GlycogenIBA 12/2017
1	ChromatinIBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Cholinergic Agents (Cholinergics)IBA 01/2016
1	Mitogen-Activated Protein Kinase 3IBA 01/2016
1	Connective Tissue Growth FactorIBA 01/2016
1	choline transporterIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	CalpainIBA 12/2015
1	Laminin (Merosin)IBA 09/2015
1	prelamin AIBA 08/2015
1	Nonsense Codon (Nonsense Mutation)IBA 11/2014
1	Protein AggregatesIBA 05/2014
1	Hormones (Hormone)IBA 08/2013

Therapy/Procedure

11	Therapeutics 10/2021 - 06/2007
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2019 - 01/2018
2	Oral Administration 11/2018 - 10/2018
2	Transplantation 05/2013 - 04/2003
1	Drug Therapy (Chemotherapy) 10/2021
1	Treatment Delay 12/2020